16 March 2021
 
 International Society of Antimicrobial Chemotherapy logo  International Society of Antimicrobial Chemotherapy facebook  International Society of Antimicrobial Chemotherapy twitter  International Society of Antimicrobial Chemotherapy LinkedIn
 
 
 
The third free webinar in ISAC's COVID-19 series has been announced. 

COVID-19 Variants: what are they and what do they mean for the global pandemic? 

is happening on 12 April 2021 at 13.00 GMT / 14.00 CET

 
As the pandemic has progressed, molecular epidemiology has been an important tool in monitoring the progress of the infection across the world. Novel variants of SARS-CoV2 have been identified and there has been much speculation about the characteristics of these variants in terms of transmissibility, pathogenicity and vaccine escape. This exciting webinar will explore these issues and the role of new virus variants in the development of the pandemic.


If you were not able to attend previous ISAC webinars you can watch them all again.


COVID-19: Around the World in 80++ Minutes
This unique webinar brought a global view of the pandemic from those on the front-line in diverse parts of the world. It covered aspects of epidemiology and genomics, screening, control, treatment and consequences of infection. The speakers, all leaders in their fields, have a unique perspective of how the pandemic affects their regions.

COVID-19: Vaccines
This timely ISAC webinar reviewed the three major vaccine candidates currently licensed for use. Three experts in their field who are also involved in their national vaccination programmes covered one of the vaccine types. The COVID-19 pandemic affects us all and it is important that we understand the new vaccines that are now available.



Regional & National MRSA Surveillance Programmes 
This webinar, sponsored and organised by ISAC's MRSA Working Group, reviewed national and regional surveillance programmes for Methicillin-Resistant Staphylococcus aureus (MRSA).

The first meeting included brief presentations from laboratories in several countries that undertake MRSA surveillance. This was followed by discussion to assess best practices. The goals were to understand the variety of approaches to surveillance worldwide and to develop principles that may underlie future harmonization of surveillance methods. 

 
 

Website

 

Helpful Links

Contact

 

Home

About Us

Working Groups

Member Societies

Meetings

Journals

Awards

Funding

Contact

Sitemap

Privacy Policy

Cookie Policy

Contact Details

Follow on Facebook

Follow on Twitter

Follow on LinkedIn

 

©Copyright International Society of Antimicrobial Chemotherapy

Unsubscribe from this newseletter
Email Read